Insider · CIK 0001625377

O'Connor Donal

Reports to the SEC for 2 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001625377

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-23	TBPHTheravance Biopharma, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−74.2K sh	—	—	6,009
2026-09-23	TBPHTheravance Biopharma, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−6,009 sh	—	—	0
2026-09-23	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,000 sh	—	—	0
2026-09-23	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,000 sh	—	—	0
2026-09-23	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,000 sh	—	—	0
2026-09-23	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,000 sh	—	—	0
2026-09-23	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−28K sh	—	—	0
2026-09-23	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−22K sh	—	—	0
2026-09-23	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−23.6K sh	—	—	0
2026-09-23	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−24.3K sh	—	—	0
2026-09-23	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.4K sh	—	—	0
2026-06-12	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+6,009 sh	—	—	80,213
2026-06-12	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award	Director	AAward	+13.4K sh	—	—	13,398
2026-05-14	PRGOPERRIGO Co plcM Exercise/Conversion	Director	MExercise/Conversion	+7,305 sh	$10.84	+$79.2K	37,942
2026-05-14	PRGOPERRIGO Co plcF Tax Payment	Director	FTax Payment	−3,507 sh	$10.84	−$38K	34,435
2026-05-14	PRGOPERRIGO Co plc · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−7,305 sh	—	—	0
2026-05-13	PRGOPERRIGO Co plc · Restricted Stock UnitsA Award	Director	AAward	+16.7K sh	—	—	16,681
2025-05-19	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+10.6K sh	—	—	74,204
2025-05-19	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award	Director	AAward	+24.3K sh	—	—	24,258
2025-05-14	PRGOPERRIGO Co plcM Exercise/Conversion	Director	MExercise/Conversion	+9,904 sh	$26.01	+$258K	35,391
2025-05-14	PRGOPERRIGO Co plcF Tax Payment	Director	FTax Payment	−4,754 sh	$26.01	−$124K	30,637
2025-05-14	PRGOPERRIGO Co plc · Restricted Stock UnitsA Award	Director	AAward	+7,305 sh	—	—	7,305
2025-05-14	PRGOPERRIGO Co plc · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−9,904 sh	—	—	0
2024-05-15	PRGOPERRIGO Co plcM Exercise/Conversion	Director	MExercise/Conversion	+8,764 sh	$30.22	+$265K	29,694
2024-05-15	PRGOPERRIGO Co plcF Tax Payment	Director	FTax Payment	−4,207 sh	$30.22	−$127K	25,487
2024-05-15	PRGOPERRIGO Co plc · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−8,764 sh	—	—	0
2024-05-14	PRGOPERRIGO Co plc · Restricted Stock UnitsA Award	Director	AAward	+9,904 sh	—	—	9,904
2024-05-08	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+10.5K sh	—	—	63,555
2024-05-08	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award	Director	AAward	+23.6K sh	—	—	23,576
2023-05-17	PRGOPERRIGO Co plcM Exercise/Conversion	Director	MExercise/Conversion	+7,778 sh	$32.86	+$256K	24,664
2023-05-17	PRGOPERRIGO Co plcF Tax Payment	Director	FTax Payment	−3,734 sh	$32.86	−$123K	20,930
2023-05-17	PRGOPERRIGO Co plc · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−7,778 sh	—	—	0
2023-05-15	PRGOPERRIGO Co plc · Restricted Stock UnitsA Award	Director	AAward	+8,764 sh	—	—	8,764
2023-05-02	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+9,132 sh	—	—	53,018
2023-05-02	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award	Director	AAward	+22K sh	—	—	22,044
2022-11-22	TBPHTheravance Biopharma, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	$10.50	−$105K	43,886
2022-05-17	PRGOPERRIGO Co plcM Exercise/Conversion	Director	MExercise/Conversion	+6,599 sh	$38.57	+$255K	20,054
2022-05-17	PRGOPERRIGO Co plcF Tax Payment	Director	FTax Payment	−3,168 sh	$38.57	−$122K	16,886
2022-05-17	PRGOPERRIGO Co plc · Restricted Stock UnitsA Award	Director	AAward	+7,778 sh	—	—	7,778
2022-05-17	PRGOPERRIGO Co plc · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−6,599 sh	—	—	0
2022-04-26	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+9,852 sh	—	—	53,886
2022-04-26	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award	Director	AAward	+28K sh	—	—	28,000
2021-05-17	PRGOPERRIGO Co plc · Restricted Stock UnitsA Award	Director	AAward	+6,599 sh	—	—	6,599
2021-05-07	PRGOPERRIGO Co plcM Exercise/Conversion	Director	MExercise/Conversion	+5,804 sh	$42.96	+$249K	16,241
2021-05-07	PRGOPERRIGO Co plcF Tax Payment	Director	FTax Payment	−2,786 sh	$42.96	−$120K	13,455
2021-05-07	PRGOPERRIGO Co plc · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−5,804 sh	—	—	0
2021-04-27	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+9,828 sh	—	—	44,034
2021-04-27	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2020-05-15	PRGOPERRIGO Co plcM Exercise/Conversion	Director	MExercise/Conversion	+6,054 sh	$52.76	+$319K	13,343
2020-05-15	PRGOPERRIGO Co plcF Tax Payment	Director	FTax Payment	−2,906 sh	$52.76	−$153K	10,437

Recent filings

Accepted (ET)
Sep 244
O'Connor Donal0001625377-26-000007
SEC(opens sec.gov)
Jun 164
O'Connor Donal0001625377-26-000004
SEC(opens sec.gov)
May 154
O'Connor Donal0001625377-26-000002
SEC(opens sec.gov)
May 214
O'Connor Donal0001415889-25-014017
SEC(opens sec.gov)
May 164
O'Connor Donal0001585364-25-000075
SEC(opens sec.gov)

Companies

Address

C/O THERAVANCE BIOPHARMA US, LLC 901 GATEWAY BLVD

SOUTH SAN FRANCISCO, CA, 94080